These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7199007)

  • 21. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antitumor effect of etoposide and its analogs].
    Kuramochi H; Okamoto K; Nishikawa K; Nagamine S; Takahashi K
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinol and beta-carotene concentrations in skin, papillomas and carcinomas, liver, and serum of mice fed retinoic acid or beta-carotene to suppress skin tumor formation.
    Jones CS; Sly L; Chen LC; Ben T; Brugh-Collins M; Lichti U; De Luca LM
    Nutr Cancer; 1994; 21(1):83-93. PubMed ID: 7910392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
    Miura T; Nogiwa E; Kurashige S; Maekawa T
    Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.
    Wilcox WS; Schabel FM; Skipper HE
    Cancer Res; 1966 May; 26(5):1009-14. PubMed ID: 5934786
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
    Benckhuijsen C
    Folia Med Neerl; 1969 Dec; 12(2):74-84. PubMed ID: 4894168
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of guanine or 6MP on anticancer activity of mycophenolic acid from the view point of inhibition of purine metabolism].
    Kagawa D; Ando S; Ueda T; Uchida M; Domae N; Nakamura T; Uchino H
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1211-6. PubMed ID: 3430015
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
    Fiszer-Maliszewska L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 32. Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations.
    Hoshino A; Albrecht AM; Hutchison DJ
    Cancer Res; 1966 May; 26(5):974-8. PubMed ID: 5934806
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia.
    Sunkara PS; Prakash NJ; Chang CC; Sjoerdsma A
    J Natl Cancer Inst; 1983 Mar; 70(3):505-9. PubMed ID: 6403743
    [No Abstract]   [Full Text] [Related]  

  • 34. Partial circumvention of resistance to 6-mercaptopurine by acylated P1,P2-bis(6-mercaptopurine-9-beta-D-ribofuranoside-5') pyrophosphate derivatives.
    Tidd DM; Gibson I; Dean PD
    Cancer Res; 1982 Sep; 42(9):3769-75. PubMed ID: 6896675
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F; Vietti T; Edelstein M
    Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755).
    Wodinsky I; Swiniarski J; Kensler CJ
    Cancer Chemother Rep; 1968 Feb; 52(2):251-5. PubMed ID: 5646852
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitumor activity of a novel synthetic polyamine analogue, N,N'-bis-[3-(ethylamino)-propyl]-1-7-heptane diamine: potentiation by polyamine oxidase inhibitors.
    Prakash NJ; Bowlin TL; Edwards ML; Sunkara PS; Sjoerdsma A
    Anticancer Res; 1990; 10(5A):1281-7. PubMed ID: 2241104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L; Maddock CL; Hall TC
    J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of chemotherapy on the kinetics of leukemic cell behavior.
    Skipper HE
    Cancer Res; 1965 Oct; 25(9):1544-50. PubMed ID: 5861078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.